Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05538416
Other study ID # UMCG202200129
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 2022
Est. completion date December 2023

Study information

Verified date September 2022
Source University Medical Center Groningen
Contact Diane H. Steenks
Phone 050 3617976
Email d.h.steenks@umcg.nl
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A combined prospective cohort study and retrospective analysis of previously collected data. Three different techniques for posterior lumbar interbody fusion (PLIF) are compared: CBT-PLIF, MI-PLIF and open PLIF. A total of 180 patients are included, who will be followed up to 6 weeks postoperatively.


Description:

A combined prospective cohort study for CBT-PLIF and retrospective analysis of prospectively collected data from the MISOS study, regarding traditional open PLIF and MI-PLIF. A total of 180 patients will be included in the study: 60 prospective CBT-PLIF patients, 60 retrospective open PLIF patients and 60 retrospective MI-PLIF patients. The new data will be collected prospectively by means of questionnaires. No biomaterial will be collected. The included patients will be asked to complete questionnaires before surgery, 2 and 6 weeks after surgery. In addition, VAS scores will be noted throughout the hospital stay, 2 and 6 weeks after surgery. Inclusion criteria: Patients aged 18-75 years with neurogenic claudication and/or radicular leg pain due to low-grade (Meyerding grades l and ll) degenerative or spondylolytic spondylolisthesis with persistent symptoms for more than 3 months. Exclusion criteria: previous spinal fusion surgery at the same level, osteoporosis (only when using bisphosphonate), active infection or previous infection at the surgical site, active cancer, spondylolisthesis grade III or greater, more than one symptomatic level requiring fusion, pregnancy, contraindication to surgery, severe mental or psychiatric disorder, substance abuse, insufficient knowledge of the Dutch language and morbid obesity (body mass index >40). Main research question: Does the CBT-PLIF provide less low back pain in the short term than the traditional open PLIF and the MI-PLIF? Primary outcome measure - Low back pain measured with the Visual Analogue Scale (VAS) 2 weeks after surgery Secondary Outcomes - Low back pain during hospitalization (measured every day), 2 and 6 weeks after surgery - Leg pain - Oswestry Disability Index - Quality of life (EQ-5D-5L) - Observed patient recovery - Other parameters such as complications, surgical parameters (intraoperative blood loss, duration of surgery), length of stay in hospital and return to work


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 180
Est. completion date December 2023
Est. primary completion date September 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - 18-75 years - Degenerative or spondylolytic spondylolisthesis - Neurogenic claudication and/or radicular leg pain - Low grade (Meyerding grade l and ll) - Persistent complaints for over 3 months Exclusion Criteria: - Previous spine fusion surgery at the same level - Osteoporosis - Active infection or prior infection at the surgical site - Active cancer - Spondylolisthesis grade lll or greater - More than one symptomatic level that needs fusion - Pregnancy - Contraindication for surgery - Severe mental or psychiatric disorder - Substance abuse - Inadequate knowledge of Dutch language - Morbid obesity (body mass index >40)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Posterior Lumbar Interbody Fusion (PLIF)
Spinal fusion in the lumbar spine by inserting a cage directly into the disc space. This is an observational study in which the standard procedure/care is followed.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Jos M. A. Kuijlen

Outcome

Type Measure Description Time frame Safety issue
Primary VAS low back pain VAS for low back pain ranging from 0mm (no pain) to 100mm (worst pain imaginable) 2 weeks postoperative
Secondary VAS low back pain VAS for low back pain ranging from 0mm (no pain) to 100mm (worst pain imaginable) During hospital stay, measured each day and 6 weeks postoperative
Secondary VAS leg pain VAS for leg pain ranging from 0mm (no pain) to 100mm (worst pain imaginable) During hospital stay, measured each day, 2 and 6 weeks postoperative
Secondary Oswestry Disability Index Used to quantify the degree of functional impairment in patients with low back pain. Ranging from 0 (no disability) to 100 (bed bound) 2 and 6 weeks postoperative
Secondary Quality of Life (QoL) Measured by the EQ-5D-5L 2 and 6 weeks postoperative
Secondary Perceived recovery of the patient scored on a 7-Likert scale, with scores ranging from 'worse than ever' to 'complete recovery' 2 and 6 weeks postoperative
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05114135 - TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study) N/A
Recruiting NCT04378543 - Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion Phase 1/Phase 2
Withdrawn NCT03223701 - Efficacy of Using Solum IV and BMC With GFC in TLIF Phase 4
Not yet recruiting NCT06000319 - Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Completed NCT00996073 - Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion Phase 2
Withdrawn NCT02530775 - "Is Instrumentation Necessary for "Static" Degenerative Spondylolisthesis" N/A
Terminated NCT03570801 - SLIP II Registry: Spinal Laminectomy Versus Instrumented Pedicle Screw Fusion N/A
Enrolling by invitation NCT04418830 - Lumbar Interbody Implant Study
Completed NCT03303300 - The Five-repetition Sit-to-stand Test for Lower Back Pain or Radiculopathy N/A
Withdrawn NCT00810212 - Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion Phase 1/Phase 2
Terminated NCT04483297 - First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) Phase 1
Completed NCT03898232 - Fibergraft Interbody Fusion Retrospective
Completed NCT00726310 - Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability
Recruiting NCT06154005 - OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion Phase 1/Phase 2
Completed NCT04418817 - Modulus in XLIF Study
Completed NCT02087267 - Lumbar Fusion With The Icotec CF/PEEK Pedicle System In Combination With The Icotec CF/PEEK TLIF Cage ETurn™
Terminated NCT01528072 - Dynesys Spinal System Post Market 522 Study N/A
Active, not recruiting NCT03733626 - Clinical Outcomes Associated With the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease N/A
Active, not recruiting NCT05993195 - Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion
Recruiting NCT06394089 - Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: Study Protocol